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Abstract
Background: The objectives of this smoking cessation study among hospitalized smokers are to: 1) determine provider
and patient receptivity, barriers, and facilitators to implementing the nurse-administered, inpatient Tobacco Tactics
intervention versus usual care using face-to-face feedback and surveys; 2) compare the effectiveness of the nurse-
administered, inpatient Tobacco Tactics intervention versus usual care across hospitals, units, and patient characteristics
using thirty-day point prevalence abstinence at thirty days and six months (primary outcome) post-recruitment; and 3)
determine the cost-effectiveness of the nurse-administered, inpatient Tobacco Tactics intervention relative to usual care
including cost per quitter, cost per life-year saved, and cost per quality-adjusted life-year saved.
Methods/Design: This effectiveness study will be a quasi-experimental design of six Michigan community hospitals of
which three will get the nurse-administered Tobacco Tactics intervention and three will provide their usual care. In
both the intervention and usual care sites, research assistants will collect data from patients on their smoking habits
and related variables while in the hospital and at thirty days and six months post-recruitment. The intervention will be
integrated into the experimental sites by a research nurse who will train Master Trainers at each intervention site. The
Master Trainers, in turn, will teach the intervention to all staff nurses. Research nurses will also conduct formative
evaluation with nurses to identify barriers and facilitators to dissemination.
Descriptive statistics will be used to summarize the results of surveys administered to nurses, nurses’ participation rates,
smokers’ receipt of specific cessation services, and satisfaction with services. General estimating equation analyses will
be used to determine differences between intervention groups on satisfaction and quit rates, respectively, with
adjustment for the clustering of patients within hospital units. Regression analyses will test the moderation of the
effects of the interventions by patient characteristics. Cost-effectiveness will be assessed by constructing three ratios
including cost per quitter, cost per life-year saved, and cost per quality-adjusted life-year saved.
Discussion: Given that nurses represent the largest group of front-line providers, this intervention, if proven effective,
has the potential for having a wide reach and thus decrease smoking, morbidity and mortality among inpatient
smokers.
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Background
Despite strong evidence for the efficacy of inpatient
smoking cessation interventions [1], implementation
of smoking cessation in hospitals has been limited.
Nurses are ideally positioned to provide smoking
cessation interventions to inpatient smokers because:
1) nurses are trained in patient education, psycho-
social, and physiological interventions; 2) physician
time is at a premium while nursing time is more
cost-effective; 3) nurses have both access to patients
and the opportunity to develop rapport with them as
well as the connection to the physicians within the
provider team; 4) nurses understand the patient’s
medical condition and can tailor the intervention ac-
cordingly; and 5) nurses can read charts, initiate
medication orders, and write nursing notes. While a
meta-analysis showed nurse-administered cessation
interventions are efficacious [2], nurse-administered
cessation interventions are seldom implemented due
to lack of training and time [3].
Over the last 12 years, our team has developed,
tested, and refined the efficacious, nurse-
administered Tobacco Tactics intervention in mul-
tiple populations including head and neck cancer
patients [4], veterans [5], and Operating Engineers
(ongoing research). In a recent Veterans Affairs (VA)
Service Directed Project [5], our team packaged the
Tobacco Tactics intervention into a toolkit and
trained 573 inpatient nurses and ancillary personnel
in two VA hospitals. Preliminary results show that
after adjusting for covariates, there was significant
improvement in self-reported six-month quit rates
for the pre- versus post-intervention time periods in
the intervention as compared to the control site.
While we are excited about the rapid dissemination
and effectiveness of the Tobacco Tactics intervention
in the VA, further rigorous testing of implementation
outside the VA system is needed. Using six of forty-
seven hospitals in the Trinity Health System, the ob-
jective of this quasi-experimental study is to com-
pare the implementation of the nurse-administered
Tobacco Tactics intervention in three hospitals com-
pared to usual care in three similar hospitals. The
specific aims are to: 1) determine provider and pa-
tient receptivity, barriers, and facilitators to imple-
menting the nurse-administered, inpatient Tobacco
Tactics intervention versus usual care using face-to-
face feedback and surveys; 2) compare the effective-
ness of the nurse-administered, inpatient Tobacco
Tactics intervention versus usual care across hospi-
tals, units, and patient characteristics using thirty-
day point prevalence abstinence at thirty days and
six months (primary outcome) post-recruitment; and
3) determine the cost-effectiveness of the nurse-
administered, inpatient Tobacco Tactics intervention
relative to usual care including cost per quitter, cost
per life-year saved, and cost per quality-adjusted life-
year saved.
Social marketing theory has been used to design and
refine the nurse-administered Tobacco Tactics interven-
tion. Social marketing is the planning and implementa-
tion of programs designed to bring about social change
using concepts from commercial marketing including
the ‘4 Ps’: 1) create an enticing ‘Product’ (that is, pack-
aging the Tobacco Tactics intervention into a toolkit for
ease of dissemination); 2) minimize the ‘Price’ the target
audience believes it must pay, such as offering continu-
ing education units (CEUs) for training, making it easy
for nurses to implement and easy for patients to access;
3) make the exchange available in ‘Places’ that reach the
audience and fit its lifestyles, such as providing training
as part of scheduled nurse training at hospitals on all
shifts; and 4) ‘Promote’ the exchange opportunity with
creativity and through channels and tactics that
maximize desired responses, such as placing a cessation
video on the hospital television station and providing a
cleverly illustrated, tailored, Tobacco Tactics patient
manual enhanced with medications and telephone
follow-up [6].
Methods/Design
Design
Since many randomized controlled trials have already
tested the efficacy of inpatient smoking cessation
interventions [1], the real challenge is integrating
these interventions into standard of care. Hence, this
effectiveness study will use a quasi-experimental de-
sign in six Michigan community hospitals of which
three will get the nurse-administered Tobacco Tac-
tics intervention and the other three will provide
usual care in accordance to how the hospital
responds to current Joint Commission (JC) hospital
accreditation standards. Implementing the interven-
tion at the facility (hospital) level was the most likely
design to remain sustainable once the study was
completed.
Throughout the entire study, smokers are surveyed
at baseline, thirty days and six months post-
recruitment. In this way, quit rates at two time
points for all patients are determined during inter-
vention (of less interest), and post-intervention in
both the Tobacco Tactics and usual care groups.
There are two sources of control. The first source of
control is pre- versus post-intervention changes
within hospitals; this source of control will NOT
control for seasonal changes. The second source of
control is changes in the Tobacco Tactics sites com-
pared to the usual care sites; this source of control
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WILL control for seasonal changes and any other
historical events that may influence quit rates across
sites.
The quasi-experimental design allows for implementa-
tion in natural environments minimizing threats to ex-
ternal validity as natural environments do not suffer the
same problems of artificiality as compared to a well-
controlled laboratory setting [7]. While quasi-experimental
designs are more feasible, the lack of randomization at the
patient level may pose many challenges in terms of internal
validity making it hard to rule out confounding variables
[8]. To minimize the effect of confounding variables, the six
hospitals have been split into two groups of three that as a
group are matched on hospital size and percentage of mi-
nority patients. While we could have arbitrarily decided
which group of three hospitals gets the intervention and
which does not, we wanted to reduce investigator bias and
used a computerized coin flip to assign the groups to ex-
perimental and control conditions. See Table 1 for the over-
all study design.
Setting and sample
The setting will be six of forty-seven hospitals in the
Trinity healthcare system, which is the fourth largest
Catholic health-care system in the United States with fa-
cilities in nine states. All units will be included, includ-
ing general medical/surgical, intensive care units/critical
care units (ICU/CCU), psychiatric mental health, obste-
trics and gynecology (OB/GYN), and pediatrics. The ra-
tionale for including all units results from our VA
experience where we found exclusion of specific units to
be unsuccessful, as specialty units initially excluded (for
example, psychiatric mental health and ICU/CCU) felt
discriminated against and felt they needed the interven-
tion at least as much as the other units. Moreover, JC
standards do not exempt specialty units therefore inclu-
sion of all units is consistent with real world standards.
That said, we recognize the need for adaptation of the
intervention to specific units such as OB/GYN or
pediatrics where the medication component may not be
applicable, but the behavioral component would still
apply. Including as many units as possible will increase
the generalizability of study findings.
Inclusion criteria for the study include inpatients that:
1) are at least 18 years of age; 2) have smoked a cigarette
within one month prior to hospitalization; 3) have a
projected hospital stay of at least 24 hours; and 4) are
willing to complete the questionnaires. The study will
exclude inpatients that: 1) refuse to participate; 2) are
involved in a concurrent trial that includes a smoking
cessation intervention; 3) are non-English speaking (the
intervention is currently only in English); 4) are unavail-
able to participate (for example, never in the room when
the research assistant attempts to consent); 5) are not
cognitively able to participate; or 6) are not physically
able to participate (see Table 2).
Power analysis
The six Trinity sites for the study (three intervention
and three control) employ 3,553 inpatient nurses that
work across fifty-eight units and discharge 98,350
patients per year (see Table 3). Of the 98,350 annual
patients served by the Trinity hospitals, we conserva-
tively estimate that 80% (78,680) of the inpatients will be
well enough to participate and, of these, 20% (15,736)
will smoke. Based on our previous studies, we anticipate
that 50% will agree to participate for a potential recruit-
ment pool of 7,868, which will be more than enough to
recruit the 2,350 smokers needed for 80% power to de-
tect a significant difference in cessation rate (the primary
outcome) assuming a 30% cessation rate in the interven-
tion group versus 20% in the usual care group, with an
alpha of .05. This power analysis was based on the pa-
tient as the unit of analysis with attention to clustering
by hospital unit. Effects of the clustering on the power
of the study were based on intraclass correlation coeffi-
cients (ICC) from our preliminary study and the number
of clusters in the design. Using the hospital unit as the
unit of clustering was justified given that the study is
quasi-experimental rather than experimental and that
any other analysis would be underpowered.
Procedures
Overview
Baseline pre-intervention smoking cessation rates will be
obtained in all hospitals (intervention and usual care con-
trol). Once baseline quit rates are achieved in all hospitals,
the Tobacco Tactics intervention will become standard of
care for all inpatient smokers in the intervention hospitals
only. That is to say, smokers who refuse to participate in
the research will still be offered the Tobacco Tactics
Table 1 Overall study design
Intervention Pre staff-intervention quit rate Staff-intervention implementation Post staff-intervention quit rate
Tobacco Tactics O1, O2 X1 O1, O2
Usual Care O1, O2 O1, O2
O=Observation (Thirty-day, six-month).
X= Intervention.
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intervention. Smokers who are not interested in quitting
smoking will at least be given brief advice to quit as this is
part of the standard of care Tobacco Tactics intervention.
Those smokers that are interested in quitting will be offered
the complete Tobacco Tactics intervention. To determine
population quit rates, all smokers, regardless of whether
they are interested in quitting smoking or not, are offered
participation in the study, that is, completing the surveys.
Smokers in the control sites will receive usual care and be
enrolled in the study to determine their quit rates. Changes
in pre- to post-intervention quit rates in the intervention
sites will be compared to changes in quit rates in the usual
care control sites during the same time period.
Enrollment of patients into the study
Throughout the pre-training, implementation, and post-
training period, smokers in all sites will be identified from
the nursing assessment at admission and approached by
a research assistant to provide written informed consent
as was done in our prior studies [9,10]. See Figure 1
for the recruitment flow chart. Participants will be
asked to complete a survey about their smoking habits
and other potential moderating variables. Research
assistants will also complete a medical record data col-
lection form that includes information such as admis-
sion and discharge date and diagnoses, comorbidities,
length of stay in the hospital, height, weight, and type
of insurance.
Follow-up
A second shorter survey will be sent to the patient
30 days after being recruited to obtain patient percep-
tions about cessation services received, satisfaction
with services, and smoking status. A longer follow-up
survey will be sent six months after recruitment to de-
termine longer-term quit rates. A modified Dillman
approach [11] will be used to follow smokers. Long-
term follow-up response rates for inpatient smoking
studies can be low, ranging from 46% to 62% [12,13].
To minimize missing data, as has been done in our
prior studies [5], those who do not respond to the
mailed surveys and postcards will be called and offered
the opportunity to complete the survey by phone with
particular emphasis on the dependent variable (quit
versus not quit). Participants will be given $10 for
each survey. In addition, to corroborate self-reported
smoking status six months post-discharge, all partici-
pants will be provided a urinary NicAlert cotinine (a
metabolite of nicotine) test strip that can be mailed
back with the survey. Those who complete the coti-
nine test will receive an additional $20 for returning
the test. In our prior similar VA study, this was found
to be a feasible method for obtaining biochemical veri-
fication as 90% of those that returned the six-month
survey also returned the urinary cotinine test strip. In
this way, quit rates in all sites (Tobacco Tactics and
usual care) will be established pre- and post-staff train-
ing. See Table 4 for a summary of survey measures.
Implementation of the Tobacco Tactics intervention
Cochrane Collaboration’s Effective Practice and Organi-
zation of Care Group found interventions that are more
active, such as educational outreach, train-the-trainer
models, and the use of opinion leaders were more effect-
ive in changing health-care provider behavior [14]. Con-
sequently, a research nurse will implement the Tobacco
Tactics intervention in the experimental sites. The pri-
mary role of the research nurse is to work with Master
Trainers in each site to implement the intervention.
Working with the research nurse, the Master Trainers
will prepare the facility for dissemination of the inter-
vention including placing the necessary materials on the
units, arranging for easy documentation, and identifying
Table 3 Description of six hospital sites
Group 1 RN
positions
Number
of units
Annual
discharges
% minorities Group 2 RN
positions
Number
of units
Annual
discharges
% minorities
Hospital 1 659 11 19,800 70% Hospital 4 502 12 18,250 31%
Hospital 2 326 9 17,000 4% Hospital 5 536 8 20,500 29%
Hospital 3 765 9 11,400 27% Hospital 6 765 9 11,400 48%
Total 1,750 29 48,200 17,618/48,200= 37% Total 1,803 29 50,150 17,075/50,150= 34%
Table 2 Eligibility criteria
Inclusion criteria
1. at least 18 years of age
2. smoked a cigarette within one month prior to hospitalization
3. projected hospital stay of at least 24 hours
4. willing to complete the questionnaires
Exclusion criteria
1. refuse to participate
2. involved in a concurrent trial that includes intervention on smoking
3. non-English speaking (the intervention is currently only in English)
4. unavailable to participate
5. not cognitively able to participate
6. not physically able to participate
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nurse champions (preferably one per unit). One incen-
tive for becoming a unit champion may be an opportun-
ity to participate in a leadership role, which may assist
with career promotion. The research nurse, along with
the Master Trainers, will provide the training sessions
on all shifts until all of the staff nurses are trained. An
incentive for staff nurses to attend is the opportunity to
obtain one Continuing Education Unit (CEU) needed for
re-licensure. Based on our prior experience, it may take
from two to six months to train the nurses depending
on the degree to which the hospital is able to release
them from the unit for training.
Identification of barriers and facilitators to implementation
Many barriers and facilitators have already been identi-
fied in our VA studies and the Trinity System hospitals
will benefit from lessons already learned. However, it
cannot be assumed that the intervention can be trans-
ferred to the Trinity sites without modification of the
implementation strategy, and the types of modifications
needed are likely to vary by unit and hospital site.
Hence, social marketing will be used to identify barriers
and facilitators to implementation of the Tobacco Tac-
tics intervention. This focus on the ‘consumer’ (both the
nurses who implement and the patients who receive the
intervention) involves in-depth research and constant
re-evaluation of every aspect of the program. The staff
nurses will be surveyed before training, immediately
after training, and again three months after the trainings
have been completed to identify barriers and facilitators
to implementation which will be kept on a log. The bar-
riers and facilitators will be discussed at research team
meetings and modifications to the implementation strat-
egy will be suggested. Moreover, patients will be sur-
veyed thirty days after their release from the hospital to
determine their satisfaction with the intervention and
whether or not they received specific aspects of the
intervention. By utilizing social marketing theory and
obtaining feedback from providers, the implementation
strategy can be modified to maximize ease of delivery.
Sustainability
By participating in process evaluation and actually seeing
changes made based on feedback given, we experienced
in our VA studies and expect to see in this study, that
sustainability will be enhanced because nurses can take
ownership of the intervention and are therefore more
motivated to keep it going. Master Trainers will ensure
that the training is incorporated into the orientation for
all new nurses. Ease of nurse documentation will be
enhanced by use of a cessation services checklist
template.
Description of the Tobacco Tactics intervention (standard
of care when all nurses are trained)
Tobacco Tactics toolkit for nurses
For nurses, the cessation toolkit includes: 1) one CEU
contact hour for training; 2) a PowerPoint presentation
on behavioral and pharmaceutical interventions; 3) a
pocket card Helping Smokers Quit: A Guide for Clini-
cians developed by U.S. Department of Health and
Human Services, Public Health Service; 4) behavioral
and pharmaceutical protocols; and 5) a computerized
template for nurse documentation. The PowerPoint
presentation covers assessment of smokers, behavioral
and pharmaceutical interventions, contra-indications for
specific groups of smokers, and case studies. The pocket
card provides an overview of behavioral and pharma-
ceutical protocols, which provide guidance for delivering
interventions.
Daily admissions report  
Identify smokers from the 
medical record 
Has not smoked a cigarette within 
one month prior to hospitalization  
Research
Assistant
visit/screening 
Projected hospital stay of less than 24 
hours 
Patient <18 years old  
Unavailable to participate  
Study Consent 
n=2,350 
Baseline Assessment
Not willing to complete the 
questionnaires 
Non-English speaking 
Concurrent smoking trial 
Refuse to participate  
Not cognitively able to participate 
Not physically able to participate   
30-Day Follow-Up
6-Month Follow-Up
Figure 1 Recruitment flow chart.
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Tobacco Tactics toolkit for patients
For patients, the cessation toolkit includes: 1) brochure;
2) videotape; 3) manual; 4) 1-800-QUIT-NOW card; 5)
pharmaceuticals; and 6) follow-up phone calls. The bro-
chure is one that we created that includes tips for quit-
ting smoking and additional resources to help patients
quit. After reviewing many possible videotapes, we
selected Smoking: Getting Ready to Quit because it was
the most appealing and informative one. The video helps
smokers develop the skills they need to quit, as well as
provides information about smoking cessation medica-
tions and dealing with withdrawal symptoms and poten-
tial relapse situations. The Tobacco Tactics manual for
patients, which has been tested among head and neck
cancer patients and veterans, was highly rated by
patients, and has been re-illustrated for a more general
population. 1-800-QUIT-NOW is a national portal that
connects smokers with the state support quitline. As
part of usual care, pharmaceuticals may be provided
using an algorithm that uses low-risk options first and
progresses to higher-risk options depending on the
patient’s smoking history, prior experience with quitting,
and contra-indications. Providing the brochure, video-
tape, and manual in advance of cessation counseling and
having a set algorithm for medications will save the
nurses’ time at the bedside.
Nurse counseling
The Tobacco Tactics intervention begins by having the
patient watch the fifteen-minute videotape, which is
placed on the overhead television to play at least twice a
day, preferably at breakfast and dinner time. The nurse
will also provide the patient with the Tobacco Tactics
manual to look over. At a later point in time, the nurse
will meet with the patient for approximately ten to
twenty minutes and provide cessation counseling which
can be broken into smaller units (for example, four five-
minute sessions) and conducted while providing routine
care. The cessation program, based on social cognitive
theory [15] and Marlatt and Gordon's relapse prevention
model [16], incorporates multiple components deemed
necessary for a successful program [17], incorporates
Agency for Healthcare Research and Quality (AHRQ)
recommendations [18] for treatment of smoking, and
Table 4 General measures and time-points
Eligibility
criteria log
Medical
records
Baseline thirty-
day
six-
month
Independent variable
Tobacco Tactics intervention versus Usual Care
Control variables
Health behaviors
• Nicotine dependence (HSI)* X X X
• Alcohol use (AUDIT-C)* X X
Clinical characteristics
• Comorbidities X
• Depression (PHQ-2)* X X
Socio-demographics
• Demographics (age, sex, race, educational level, marital status, employment, hospital site)* X X X
Dependent variables/outcomes
Aim 1: Provider and patient receptivity, barriers, and facilitators to implementation
• Face-to-face feedback Ongoing
• Surveys Pre-, post-, and three months post-training
Aim 2: Cessation efficacy
• Thirty-day/six-month* reported smoking X X
• Six-month cotinine test* X
Aim 3: Cost-effectiveness
• Cost per quitter X X
• Cost per life-year saved X X
• Cost per quality-adjusted life-year saved (EQ-5D) X X
* These measures/protocols are common to all CHART studies.
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tailors the intervention to the individual patient’s med-
ical condition and lifestyle. For example, those with low
nicotine dependence may only receive behavioral coun-
seling while those with high nicotine dependence may
receive both behavioral counseling and medication. The
behavioral component of the intervention can be tai-
lored to the patient and, as outlined in the Tobacco Tac-
tics manual, includes: 1) health consequences of
smoking; 2) smoker self-assessment; 3) identifying
smoker type; 4) change worksheet; 5) money-saving ad-
vantage; 6) goal setting; 7) handling thoughts about
smoking; 8) assessing high-risk situations; 9) common
triggers; 10) coping with cravings; 11) coping with
relapses; 12) benefits of quitting; and 13) guided im-
agery. The pharmaceutical component of the interven-
tion includes a medication protocol used in our prior
studies. Pharmacological management will be initiated
by the nurse in consultation with the patient’s physician.
This will take place just as any discussions between
nurses and physicians occur in the context of the pro-
viding of health care to patients in the hospital setting.
See Appendix A and Appendix B for an outline of the
behavioral and pharmaceutical protocols [5].
Physician advice
While this is primarily a nurse-delivered intervention,
brief physician advice has been shown to enhance quit
rates [19]. In our previous VA study, we considered a
number of tactics to encourage physician advice includ-
ing clinical reminders, which were not acceptable to
physicians. Based on this feedback, we have had great
success coupling a physician reminder for brief advice
along with medication sign-off, which once implemented
was very sustainable.
Telephone counseling
Studies [20-22] have shown that telephone counseling is
efficacious to reinforce the initial intervention visit, pro-
mote skills building, and monitor pharmacologic treat-
ment. Yet, our experience has been that, due to cost and
procedural barriers, telephone counseling is one of the
most difficult components of inpatient cessation interven-
tions to implement and sustain. After exploring several
unsuccessful options, we have had great success imple-
menting telephone follow-up through Voluntary Services.
Working with the director of Voluntary Services, we
will handpick and train volunteers to provide the tele-
phone cessation counseling. Volunteers will be former
(at least one year quit) or non-smokers who have good
social skills and are interested in providing direct patient
care. Volunteer training consists of: 1) participating in
the one-hour Tobacco Tactics training program; 2) view-
ing the video shown to patients about smoking cessa-
tion; and 3) viewing a video Tools for Being a Helpful
Peer Partner about peer support that has been used in
other studies [23]. The video demonstrates three types
of communication skills: asking open questions; reflect-
ive listening; and encouraging efforts to make change.
The video helps the individuals understand that when
two people share experiences, it can be a very powerful
way for them to help each other cope and make good
health decisions. The video describes and models Motiv-
ational Interviewing (MI)-style communication skills for
peer-to-peer communications, explains the basics of MI-
style communications, and provides numerous examples
of peer-to-peer conversations that use MI techniques.
Using the Tobacco Tactics manual as a guide, volun-
teers will be given a script that covers three important
aspects of providing support to smokers, namely 1) posi-
tive reinforcement; 2) handling thoughts about smoking;
and 3) strategies to cope with cravings. Volunteers will
be supervised making calls until the Master Trainer is
comfortable with their performance and they follow the
protocol appropriately. Volunteers will provide only be-
havioral support and refer all medical questions or un-
anticipated situations/crises to case managers or 911.
There is a documentation template that allows for the
nurse to tick off the components of the intervention
provided including counseling and medications. If the
nurse ticks off on the documentation template that the
patient was given the Tobacco Tactics manual, the med-
ical record is programmed to add the patient’s name and
phone number to a list that is forwarded to Voluntary
Services on a weekly basis. Volunteers then provide peer
telephone cessation counseling to patients at two, seven,
fourteen, twenty-one, and thirty days after discharge.
Since volunteers cannot access or chart in the medical
record, paper documentation can be placed in the paper
record or scanned into the electronic record by medical
records personnel.
Fidelity of intervention
Fidelity checks will be conducted by research staff who
will observe 5% of staff and volunteers implementing the
intervention. These fidelity checks will establish if the
components of the Tobacco Tactics intervention are being
implemented. Based on these fidelity checks, changes to
the implementation strategy may be introduced.
Description of usual care
The comparison group will receive usual care [24] in ac-
cordance to how the hospital responds to current JC stan-
dards. Current JC standards require that inpatient
smokers with acute myocardial infarction (AMI), congest-
ive heart failure (CHF), community-acquired pneumonia
receive adult smoking cessation advice/counseling. Smok-
ing cessation advice/counseling must include at least one
of the following: advice to stop smoking, brochures or
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handouts on smoking cessation, a smoking cessation aid
such as nicotine patch, gum, nasal spray, inhaler, lozenge,
or sustained-release bupropion, viewed a smoking cessa-
tion video [25]. In the Trinity health-care system, all inpa-
tients are screened for smoking and smokers are given
advice to stop smoking.
Measures
The measures for the CHART study group have been
described in detail in the overview article and are summar-
ized in Table 4. In brief, the main outcome measures include
self-reported thirty-day point abstinence prevalence at six
months and biochemically verified abstinence at six months.
Additional measures include the Heavy Smoking Index
(HSI) for nicotine dependence [26], the Patient Health
Questionnaire 2 (PHQ-2) for depression [27], the Alcohol
Use Disorders Identification Test–C (AUDIT-C) for alcohol
use [28,29], and demographics (age, sex, race, educational
level, marital status, employment, hospital site). At thirty-
day follow-up, patients are also asked whether they received
specific aspects of the intervention and about their satisfac-
tion with the intervention. The EuroQol (EQ-5D) will be
used to calculate cost per quitter, cost per life-year saved,
and cost per quality-adjusted life-year saved [30].
Additional process measures, some of which will evalu-
ate sustainability, include facility tobacco performance
measures, whether or not materials are being used (for ex-
ample, Tobacco Tactics manuals), whether the Tobacco
Tactics training gets integrated into new nurse training,
number of follow-up counseling calls made to patients,
nurse confidence in delivering the intervention, nurse self-
report that they are continuing to implement at three-
month post-training, and patient report of, receipt of, and
satisfaction with the components of the intervention.
Some sample questions include: ‘How confident are you
in your abilities to provide smoking cessation services to
smokers?’ ranging from ‘Not at all confident’ to ‘Extremely
confident’ and ‘Please indicate why you do not expect to
provide these services’ with choices of ‘Lack of confidence,’
‘Not enough training,’ ‘Not enough time,’ ‘Hesitant to upset
patients,’ ‘Not my job,’ and ‘Other’. Post-intervention mea-
sures will be compared to pre-intervention measures both
within and across sites.
Data analysis
All analyses that compare the two treatment groups will
use the intent-to-treat approach in which patients’ data
are analyzed based on the treatment intended, not on the
treatment actually received. This approach is taken be-
cause it is the best method for evaluating the potential
effects of disseminating the Tobacco Tactics intervention,
which is our focus. Another implication of this approach
is that the approximately 25% of patients who are lost to
follow-up are included which assures that differences
between conditions are not actually due to differential
drop out. Extensive follow-up will be conducted including
by telephone to minimize the amount of missing data. Sta-
tistically justified imputation methods such as multiple
imputation will be used to allow analyses including those
who have dropped out.
Analyses will adjust for clustering for patients within
units using generalized estimating equations (GEE) ana-
lyses. GEE is a method of analysis that can account for
the correlations among responses from patients in the
same cluster [31]. Given the structure of the study with
patients nested within hospital units, the hospital unit
will be treated as the cluster. The correlation matrix will
be of the exchangeable form, assuming the same correl-
ation among any pair of patients in the same hospital
unit. This is standard structuring of the matrix for ana-
lyzing clustered non-longitudinal data. Given concerns
that GEE might be biased with a small number of units,
the adjustment for that factor recommended by Morel
[32] will be used for each GEE analysis.
There is concern that individual hospitals might differ
in factors that influence implementation and effectiveness
of the intervention. Though the study would be under-
powered to use the hospital as the unit of clustering, sev-
eral strategies will be used to counter the effects of
hospital differences on our finding. If there are baseline
differences in the type of patients among the six hospitals,
we can control for these differences by adding these vari-
ables as covariates in the analysis. If there are multiple dif-
ferences and we are underpowered to add all of these
variables as covariates, we will create a propensity score to
control for these differences. Note the quit rates and other
factors will be assessed in all hospitals before the interven-
tion is conducted in any of them. Comparison of the post-
intervention quit rates to the pre-intervention quit rates
(and post and pre levels of other outcomes) is built into
the analyses.
Aim 1: Determine provider and patient receptivity, barriers,
and facilitators to implementing the nurse-administered,
inpatient Tobacco Tactics intervention versus usual care
using face-to-face feedback and surveys
Descriptive statistics (means and frequency distribu-
tions) will be used to summarize the nurses’ survey
results. Patient participation rates will be calculated by
dividing the number of inpatient smokers that partici-
pated by all smokers screened and found to be eligible
to participate. Descriptive statistics will be calculated to
determine if smokers were offered specific cessation ser-
vices, whether they participated in these services, and
their satisfaction with these services. Satisfaction rates of
80% are anticipated because our similar in-clinic smok-
ing cessation intervention with head and neck cancer
patients had similar rates [4]. To test for differences
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between the Tobacco Tactics and usual care sites in ser-
vices received (yes/no) and satisfaction with those ser-
vices (scale of one to five), GEE analysis using a link
function of logit (for dichotomous dependent measures)
or identity (for quantitative dependent measures) with
adjustment for the clustering of patients within units will
be conducted. GEE analysis is designed for data that are
collected in clusters (the hospital units) and works with
data with a wide variety of distributions.
Aim 2: Compare the effectiveness of the nurse-administered,
inpatient Tobacco Tactics intervention versus usual care
across hospitals, units, and patient characteristics using
thirty-day point prevalence abstinence at thirty days and
six months (primary outcome) post-recruitment
Patients will report on their smoking status (thirty-day
point prevalence) at thirty days and six months (primary
outcome variable) post-recruitment. At six months, all
study participants will be asked to return the completed
cotinine test. Descriptive statistics (percentage quit for
seven and/or thirty days at six months) will be computed
and reported for the hospitals and units in each condition.
The standard errors will be computed taking into account
the clustering of patients within units. GEE analyses
analogous to logistic regression, but adjusting for the clus-
tering of patients within units, will be used to compare
the pre- and post-intervention quit rates in the interven-
tion as compared to the usual care control hospitals. Re-
call that in every hospital, quit rates will be assessed both
before and after implementation of the intervention
(whether or not the hospital is among those receiving the
intervention). Whether the baseline quit rates differ or not
between hospitals, baseline quit rates will be considered in
analyses to meet this objective.
Smoking quit rates will be assessed throughout the im-
plementation phase to assess whether cessation rates are
improving; however, the primary outcome is the smoking
cessation rates at the time when the intervention is inde-
pendently being conducted by hospital staff. Descriptive
statistics will be computed and reported. Preliminary
analyses will use chi-square tests of association to com-
pare the quit rates in the hospitals in each condition.
We anticipate a quit rate of 30% in the hospitals re-
ceiving the Tobacco Tactics intervention and 20% in the
usual care hospitals. However, to assure that these differ-
ences are not just due to differences between the hospi-
tals, a GEE analysis will be conducted using the logit
link function with the hospital unit as the definition of
the cluster analogous to moderated logistic regression
analysis in which quitting is predicted by time frame
(baseline versus intervention period), intervention group
(Tobacco Tactics versus usual care), and the product of
those two variables. The statistical significance of the
product will indicate that the difference between the
Tobacco Tactics and the usual care comparison sites
depends on whether or not the intervention has been
implemented. We anticipate no difference between the
sites at baseline, but a notable difference after the inter-
ventions have been implemented.
In addition, harm reduction will be compared between
the two groups by analyses of number of cigarettes
smoked per day, number of quit attempts, and nicotine
dependence (as indicated by Fagerstrom test). For each
of these analyses, the same general approach taken to
the primary dependent variable will be applied including:
descriptive statistics on baseline and intervention period
and a GEE with the hospital unit as the definition of the
cluster analogous to moderated regression analysis to
compare the differences between the sites (Tobacco Tac-
tics versus usual care) by time (baseline versus interven-
tion period). Both the descriptive statistics and the
significance tests differ for these other outcome mea-
sures because of their different distributions (that is,
normal or not). Count variables will be analyzed assum-
ing a Poisson distribution using a log link function while
the Fagerstrom test scores will be modeled with an iden-
tity link function since it is normally distributed.
Other analyses related to aim 2 will test the moderation
of the effects of the interventions by selected patient
characteristics. We hypothesize that patients will be
more likely to quit if they have higher confidence in abil-
ity to quit, higher education level, lower addiction, lower
alcohol intake, and a smoking-related diagnosis such as
heart disease. We will also test whether the effects of the
specific intervention (Tobacco Tactics or usual care)
received are moderated by these factors. All of these
effects will all be tested by GEE analyses analogous to
moderated regression analyses (whether logistic, linear,
or Poisson) including product terms to test the inter-
action of these factors with the intervention received.
Aim 3: Determine the cost-effectiveness of the nurse-
administered, inpatient Tobacco Tactics intervention versus
usual care including the cost per quitter, cost per life-year
saved, and cost per quality-adjusted life-year saved
Using both societal and health system perspectives, cost-
effectiveness will be assessed by constructing three
ratios. The incremental cost-effectiveness ratio (ICER) is
the difference in average costs between the Tobacco Tac-
tics and the usual care groups divided by the difference
in average effectiveness between the two groups. First,
we will calculate the cost per quitter (incremental cost
of achieving cessation for those in the Tobacco Tactics
intervention compared to usual care). The numerator
will be calculated by subtracting the cost of usual care
from the cost of the Tobacco Tactics intervention, and
the denominator will be based on the difference in quit
rates between the two groups. No discount rate will be
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applied since both the costs and quits will occur within
the same period of time. Second, we will estimate the
cost per life-year saved, defined for this study as the cost
per lifetime quitter divided by the number of life-years
saved per lifetime quitter. The potential number of life-
years saved will be obtained using published data and
the use of Monte Carlo simulation. A similar procedure
will also be used to estimate the cost per quality-
adjusted life-year (QALY) [33]. A discount rate of 3%
will be applied to the estimated life-years and quality-
adjusted life years saved since current life-years are gen-
erally considered to be of greater value than future life-
years [34]. Sensitivity analyses will be used to test other
input values in the life-years and QALYs models (for ex-
ample, 1% or 5% rather than 3% discount rate, other
estimates of relapse rates). Both short-term costs (during
the intervention period) and long-term costs (down-
stream total medical care costs, including pharmacy, in-
patient, and outpatient costs) will be calculated.
Discussion
The nurse-administered Tobacco Tactics intervention is
innovative in that, aside from having all of the expected
components of guideline recommendations [18] for be-
havioral and pharmaceutical cessation interventions, social
marketing strategies have been used to obtain consumer
feedback to develop the intervention and materials, which
patients and staff have found to be engaging. The Tobacco
Tactics intervention has been packaged into a toolkit for
nurses and patients, which makes it easy to implement
and export to other facilities. By training all nurses, the
largest group of front-line providers, there is a possibility
for a wide reach of the intervention.
The study design is novel in that it implements the
intervention at the facility level, which enhances sus-
tainability when the study ends and minimizes cross-
contamination between intervention and comparison
arms. Comparing the Tobacco Tactics intervention to
‘real world’ usual care will provide for careful testing
of the intervention. The sample is novel in that it uses
a network of community hospitals that may serve as
an avenue for broader dissemination at the end of the
study. Implementation strategies, many recommended
by providers themselves, make the Tobacco Tactics
intervention easy to integrate into busy inpatient units.
The design is in concert with a recent Institute of
Medicine (IOM) report which discusses the need for dir-
ect comparison of effective interventions in typical day-
to-day clinical care including smoking cessation inter-
ventions [35]. Moreover, the design is consistent with
the recommendations in the American Recovery and Re-
investment Act of 2009 which suggests studying out-
comes of the organization and delivery of care including
translation and dissemination efforts ensuring that evi-
dence from comparative effectiveness research is access-
ible to and usable by patients and other consumers,
providers, payers, and policy makers [36]. Priorities cited
by this act include increasing the capacity for practical
experimental and quasi-experimental comparative effect-
iveness studies; emphasizing the evaluation of broad,
health system-level strategies to improve the quality and
value of care; identifying subgroups of patients most
likely to benefit from a given intervention; and increas-
ing the emphasis on developing and evaluating strategies
to disseminate research results and encourage the use of
evidence in the care of individuals and patient popula-
tions [37]. By assigning hospitals rather than patients to
conditions, we are really testing the applicability of the
intervention in real world settings.
The idea behind implementing the Tobacco Tactics
program at the hospital level is that, as we move to-
ward population-based public health approaches to
address smoking, our goal is to get the largest num-
ber of quits given a fixed unit of investment. The re-
turn on investment is a function of the potential
reach of the program, the effectiveness of the pro-
gram, and the cost of delivering the program. What
we are looking for is high reach, high effectiveness,
and low cost. Imagine the enormous reach and pub-
lic health impact of an inpatient smoking cessation
intervention if all of the largest group of front-line
providers, namely nurses, were trained to effectively
provide the Tobacco Tactics intervention.
Trial status
Human studies approval was obtained from all partici-
pating sites. As of May 2012, 651 participants out of
2,350 have been recruited. Recruitment is ongoing.
Appendix A. Smoking cessation behavioral
management protocol
1. Assess if patient interested in quitting.
2. If patient not interested, leave brochure at bedside.
3. If patient interested, leave brochure and arrange for
patient to view videotape.
4. After videotape, provide patient with patient manual
to read if able.
5. Using patient manual, assist patient with behavioral
intervention including:
a. self-assessment,
b. smoker type,
c. smoking costs,
d. handling cravings,
e. relapse prevention, and
f. medication options.
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6. Along with patient, identify and arrange for
cessation medications (see pharmaceutical
protocol).
7. Arrange for follow-up calls [5].
Appendix B. Smoking cessation pharmaceutical
management protocol
1. Recommend nicotine replacement (patch, gum, or
lozenge) if:
a. never used patch, gum, or lozenge before,
b. used patch, gum, or lozenge successfully in the
past (smoke-free >3 months).
2. Recommend nicotine replacement (patch AND gum
OR lozenge) if:
a. smoke greater than one pack per day, and
b. failed nicotine replacement therapy in past.
3. Recommend Bupropion if:
a. failed nicotine replacement therapy in the past
(smoke-free <3 months)
b. patch, gum, or lozenge intolerant (that is, rash,
and so on), and
c. history of depression or currently has depressive
symptoms.
4. Recommend combination nicotine replacement
(patch, gum, or lozenge) and bupropion if:
a. failed nicotine replacement and bupropion
monotherapy in the past.
5. Recommend varenicline if:
a. intolerance or treatment failure to nicotine
replacement and bupropion [5].
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